Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins

Journal of Cell Biology - Tập 169 Số 1 - Trang 167-177 - 2005
Elena Zaitseva1, Aditya Mittal1,2, Diane E. Griffin3, Leonid Chernomordik1
11Section on Membrane Biology, Laboratory of Cellular and Molecular Biophysics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892
22Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, New Delhi, India 110016
33W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205

Tóm tắt

Viral fusion proteins of classes I and II differ radically in their initial structures but refold toward similar conformations upon activation. Do fusion pathways mediated by alphavirus E1 and influenza virus hemagglutinin (HA) that exemplify classes II and I differ to reflect the difference in their initial conformations, or concur to reflect the similarity in the final conformations? Here, we dissected the pathway of low pH–triggered E1-mediated cell–cell fusion by reducing the numbers of activated E1 proteins and by blocking different fusion stages with specific inhibitors. The discovered progression from transient hemifusion to small, and then expanding, fusion pores upon an increase in the number of activated fusion proteins parallels that established for HA-mediated fusion. We conclude that proteins as different as E1 and HA drive fusion through strikingly similar membrane intermediates, with the most energy-intensive stages following rather than preceding hemifusion. We propose that fusion reactions catalyzed by all proteins of both classes follow a similar pathway.

Từ khóa


Tài liệu tham khảo

2000, Biophys. J., 78, 227, 10.1016/S0006-3495(00)76587-8

1996, J. Cell Biol., 135, 63, 10.1083/jcb.135.1.63

2003, Virology., 316, 234, 10.1016/j.virol.2003.07.006

2004, EMBO J., 23, 728, 10.1038/sj.emboj.7600064

1993, EMBO J., 12, 693, 10.1002/j.1460-2075.1993.tb05703.x

2003, Annu. Rev. Biochem., 72, 175, 10.1146/annurev.biochem.72.121801.161504

1993, FEBS Lett., 318, 71, 10.1016/0014-5793(93)81330-3

1997, J. Cell Biol., 136, 81, 10.1083/jcb.136.1.81

1998, J. Cell Biol., 140, 1369, 10.1083/jcb.140.6.1369

1997, Virology., 238, 14, 10.1006/viro.1997.8799

2000, Virology., 269, 37, 10.1006/viro.1999.0172

1996, J. Cell Biol., 133, 559, 10.1083/jcb.133.3.559

1985, J. Cell Biol., 101, 19, 10.1083/jcb.101.1.19

2005, Curr. Top. Microbiol. Immunol., 285, 25

1999, J. Mol. Biol., 286, 489, 10.1006/jmbi.1998.2500

1996, J. Virol., 70, 7371, 10.1128/jvi.70.11.7371-7378.1996

2003, Cell., 114, 573, 10.1016/S0092-8674(03)00683-4

2004, J. Virol., 78, 3312, 10.1128/JVI.78.7.3312-3318.2004

2004, Nature., 427, 320, 10.1038/nature02239

2000, J. Cell Biol., 151, 453, 10.1083/jcb.151.2.453

2004, Science., 304, 289, 10.1126/science.1095801

2003, Cell., 112, 519, 10.1016/S0092-8674(03)00112-0

1994, Cell., 76, 383, 10.1016/0092-8674(94)90344-1

1996, J. Cell Biol., 134, 863, 10.1083/jcb.134.4.863

2000, J. Virol., 74, 7529, 10.1128/JVI.74.16.7529-7537.2000

2002, Traffic., 3, 256, 10.1034/j.1600-0854.2002.030403.x

2000, Mol. Biol. Cell., 11, 2359, 10.1091/mbc.11.7.2359

2001, Biochemistry., 40, 8378, 10.1021/bi010466+

2002, EMBO J., 21, 5701, 10.1093/emboj/cdf559

2001, Cell., 105, 137, 10.1016/S0092-8674(01)00303-8

1995, Curr. Opin. Cell Biol., 7, 509, 10.1016/0955-0674(95)80007-7

2001, J. Virol., 75, 8329, 10.1128/JVI.75.17.8329-8339.2001

1998, J. Cell Biol., 143, 1155, 10.1083/jcb.143.5.1155

2001, J. Cell Biol., 155, 833, 10.1083/jcb.200103005

2004, Virology., 325, 200, 10.1016/j.virol.2004.04.043

1997, J. Cell Biol., 136, 995, 10.1083/jcb.136.5.995

1997, Virology., 235, 118, 10.1006/viro.1997.8686

2000, J. Cell Biol., 151, 413, 10.1083/jcb.151.2.413

2003, Biophys. J., 85, 1713, 10.1016/S0006-3495(03)74601-3

2004, Nature., 427, 313, 10.1038/nature02165

1994, EMBO J., 13, 2797, 10.1002/j.1460-2075.1994.tb06573.x

1998, J. Virol., 72, 1534, 10.1128/JVI.72.2.1534-1541.1998

2004, Virology., 324, 373, 10.1016/j.virol.2004.03.046

2003, Nat. Struct. Biol., 10, 1048, 10.1038/nsb1012

2001, Nature., 409, 581, 10.1038/35054500

1996, J. Cell Biol., 135, 1831, 10.1083/jcb.135.6.1831

2002, Virology., 297, 128, 10.1006/viro.2002.1429

1987, J. Cell. Physiol., 131, 200, 10.1002/jcp.1041310209

2001, EMBO J., 20, 4024, 10.1093/emboj/20.15.4024

2002, J. Virol., 76, 12691, 10.1128/JVI.76.24.12691-12702.2002

1996, Biochemistry., 35, 4956, 10.1021/bi9526903

2003, Bioessays., 25, 672, 10.1002/bies.10301

2003, J. Virol., 77, 3441, 10.1128/JVI.77.6.3441-3450.2003

2000, Annu. Rev. Biochem., 69, 531, 10.1146/annurev.biochem.69.1.531

1999, J. Virol., 73, 8476, 10.1128/JVI.73.10.8476-8484.1999

2002, FEBS Lett., 521, 62, 10.1016/S0014-5793(02)02823-5

2004, J. Virol., 78, 8536, 10.1128/JVI.78.16.8536-8542.2004

2004, Science, 306, 813

2002, Science., 297, 1349, 10.1126/science.1073806

2003, Biochim. Biophys. Acta., 1614, 14, 10.1016/S0005-2736(03)00159-7

1993, J. Biol. Chem., 268, 25764, 10.1016/S0021-9258(19)74455-X

2002, J. Biol. Chem., 277, 38141, 10.1074/jbc.M206998200

1998, Cell., 92, 759, 10.1016/S0092-8674(00)81404-X

1980, Proc. Natl. Acad. Sci. USA., 77, 3273, 10.1073/pnas.77.6.3273